TABLE 2.

Changes in Outcome Variables (from Baseline to Follow-Up) Between Study Groups*

Type 2 DiabetesNew vs. No Diabetes Groups(mean change [95% CI]; P)
No (mean change [95% CI]; P)New(mean change [95% CI]; P)
Body weight (kg)0.69 (0.43–0.96); <0.0001–0.67 (–1.21 to –0.14); 0.014–1.38 (–1.85 to –0.89); <0.0001
Sitting (h/day)–0.55 (–0.70 to –0.42); <0.0001–0.36 (–0.61 to –0.10); 0.0060.19 (–0.03 to 0.42); 0.101
Walking (min/week)2.08 (–8.63 to 12.79); 0.70312.87 (–8.14 to 33.88); 0.22810.79 (–7.82 to 29.39); 0.256
MVPA (min/week)10.44 (–20.56 to 41.44); 0.509–2.34 (–64.01 to 59.33); 0.941–11.51 (–66.36 to 43.34); 0.680
Fruit consumption (servings/day)–0.14 (–0.18 to –0.10); <0.0001–0.08 (–0.16 to –0.003); 0.0430.05 (–0.02 to 0.12); 0.148
Vegetable consumption (servings/day)–0.45 (–0.54 to –0.36); <0.0001–0.24 (–0.42 to –0.09); 0.0110.21 (0.05–0.38); 0.011
Cigarettes smoked (n/day)–0.41 (–1.41 to 0.61); 0.469–2.23 (–4.62 to 0.17); 0.069–1.82 (–4.03 to 0.39); 0.107
No (%)New (%)New vs. No Diabetes Groups (odds of quitting [95% CI]; P)
Cessation of smoking§30.850.02.71 (1.59–4.63); 0.0002
  • * Mean adjusted for baseline and demographic characteristics.

  • Incident or new cases (participants who did not report type 2 diabetes at the baseline survey but did report type 2 diabetes at the follow-up survey).

  • Among participants who reported smoking at both the baseline and follow-up surveys.

  • § Among participants who reported smoking at the baseline survey.